Table 6 Change in cardiovascular and diabetic drug therapy 1 year post scan based on having a normal or abnormal stress perfusion cardiac magnetic resonance (CMR) examination
| Â | 1Â year change in medications | Â | |
|---|---|---|---|
Normal CMR (n = 36) | Abnormal CMR (n = 27) | p | |
Anti-hypertensives | |||
 Beta-blockers | +2 | +4 | 0.39 |
 ACE inhibitor | +1 | +3 | 0.80 |
 Calcium channel blockers | −1 | +4 | 0.03* |
 Alpha-blockers | 0 | +2 | 0.76 |
 Diuretics | 0 | +3 | 0.07 |
 ARB | +1 | 0 | 1.00 |
Lipid-modifying agents | |||
 Statin | +1 | +8 | 0.01* |
 Fibrates | 0 | 0 | 1.00 |
Anti-hyperglycaemic agents | |||
 Acarbose | −1 | +1 | 0.68 |
 Sulfonylureas | 0 | 0 | 1.00 |
 SGLT-2 inhibitor | +2 | +3 | 0.64 |
 Metformin | +1 | +1 | 1.00 |
 DDP-4 inhibitor | +2 | −1 | 0.23 |
 Insulin | 0 | +1 | 0.68 |
 Pioglitazone | +3 | +2 | 1.00 |
Anti-platelet agents | |||
 Clopidogrel | 0 | +8 | 0.001* |
 Aspirin | 0 | +12 | < 0.001* |